Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed (MYNZ) Research & Development (2022 - 2023)

Historic Research & Development for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to $2.0 million.

  • Mainz Biomed's Research & Development fell 3972.56% to $2.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $10.0 million, marking a year-over-year increase of 9838.54%. This contributed to the annual value of $5.8 million for FY2024, which is 3911.58% down from last year.
  • Per Mainz Biomed's latest filing, its Research & Development stood at $2.0 million for Q4 2023, which was down 3972.56% from $1.9 million recorded in Q3 2023.
  • Mainz Biomed's 5-year Research & Development high stood at $3.5 million for Q2 2023, and its period low was $229916.0 during Q2 2022.